ArticleInternational journal of molecular sciences2017

Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors.

Tatsuo Kanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.